Lv55
1220 积分 2021-11-03 加入
Orforglipron, an Oral Small-Molecule GLP-1 Receptor Agonist, in Early Type 2 Diabetes
4小时前
已完结
A Randomized Trial of Automated Insulin Delivery in Type 2 Diabetes
3天前
已完结
国家基层糖尿病神经病变诊治指南（2024版）
1个月前
已完结
Efficacy and safety of oral semaglutide with flexible dose adjustment versus sitagliptin in type 2 diabetes (PIONEER 7): a multicentre, open-label, randomised, phase 3a trial
1个月前
已关闭
Efficacy and safety of the addition of a dipeptidyl peptidase-4 inhibitor to insulin therapy in patients with type 2 diabetes: A systematic review and meta-analysis
2个月前
已完结
Continuous glucose monitoring-based metrics and the duration of hypoglycaemia events with once-weekly insulin icodec versus once-daily insulin glargine U100 in insulin-naive type 2 diabetes: an exploratory analysis of ONWARDS 1
2个月前
已关闭
Continuous glucose monitoring-based metrics and the duration of hypoglycaemia events with once-weekly insulin icodec versus once-daily insulin glargine U100 in insulin-naive type 2 diabetes: an exploratory analysis of ONWARDS 1
2个月前
已完结
钠-葡萄糖共转运蛋白2抑制剂在2型糖尿病患者中的临床应用获益及潜在风险
4个月前
已完结
中国药物性肝损伤诊治指南（2023年版）
4个月前
已完结
中文版8条目Morisky服药依从性量表在2型糖尿病患者中的信效度评价及应用研究
4个月前
已关闭
皖公网安备34019202002308
